MENU
+Compare
GMED
Stock ticker: NYSE
AS OF
Jun 6 closing price
Price
$59.92
Change
+$0.37 (+0.62%)
Capitalization
7.19B

GMED Globus Medical Forecast, Technical & Fundamental Analysis

Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers... Show more

GMED
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for GMED with price predictions
May 28, 2025

GMED sees its Stochastic Oscillator recovers from oversold territory

On May 20, 2025, the Stochastic Oscillator for GMED moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 58 instances where the indicator left the oversold zone. In of the 58 cases the stock moved higher in the following days. This puts the odds of a move higher at over .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where GMED's RSI Indicator exited the oversold zone, of 28 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on May 23, 2025. You may want to consider a long position or call options on GMED as a result. In of 88 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where GMED advanced for three days, in of 327 cases, the price rose further within the following month. The odds of a continued upward trend are .

GMED may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for GMED turned negative on May 09, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where GMED declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for GMED entered a downward trend on May 20, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GMED’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.799) is normal, around the industry mean (24.345). P/E Ratio (49.654) is within average values for comparable stocks, (79.080). Projected Growth (PEG Ratio) (1.799) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (3.883) is also within normal values, averaging (42.837).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. GMED’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
GMED
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

GMED is expected to report earnings to rise 15.97% to 78 cents per share on July 31

Globus Medical GMED Stock Earnings Reports
Q2'25
Est.
$0.79
Q1'25
Missed
by $0.07
Q4'24
Beat
by $0.10
Q3'24
Beat
by $0.18
Q2'24
Beat
by $0.07
The last earnings report on May 08 showed earnings per share of 68 cents, missing the estimate of 75 cents. With 860.13K shares outstanding, the current market capitalization sits at 7.19B.
A.I. Advisor
published General Information

General Information

a manufacturer of spinal implants

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
2560 General Armistead Avenue
Phone
+1 610 930-1800
Employees
5000
Web
https://www.globusmedical.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

GMED and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, GMED has been loosely correlated with VREX. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if GMED jumps, then VREX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GMED
1D Price
Change %
GMED100%
-0.64%
VREX - GMED
49%
Loosely correlated
+0.38%
CTKB - GMED
47%
Loosely correlated
-3.11%
GKOS - GMED
42%
Loosely correlated
-2.07%
CVRX - GMED
42%
Loosely correlated
-3.02%
MMSI - GMED
40%
Loosely correlated
-2.15%
More